Bristol Myers Squibb, GSK, and Novo Nordisk Join Alliance for Genomic Discovery

Illumina Official WeChat News, on January 5th, gene sequencing and chip technology company Illumina (NASDAQStock Code: ILMN) and clinical and genomic data company, Nashville Biosciences, LLC (NashBio), a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), announced three new members of the Alliance for Genomic Discovery (AGD). Bristol-MyersBristol-Myers Squibb、GSKAndNovo NordiskJoined the founding member organizationAbbVie、Amgen、AstraZeneca、BayerAndMerck & Co.The ranks. These member pharmaceutical companies will jointly fund the whole genome sequencing of 250,000 DNA samples and gain access to the sequencing data for drug discovery and therapy development.

Editor: Guo Mingyu